The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery.

Our Smart approach of designing and selecting compound libraries facilitates a rapid and efficient lead discovery process, yielding lead compounds with excellent pharmacological profiles.

We use proprietary software algorithms for compound design and selection and a Global Supplier Database of nearly all commercially available screening compounds to provide our clients with screening libraries that are tailored to their specific needs.

Pyxis Discovery is headquartered in the Netherlands and has a worldwide presence with also an office in Boston, Massachusetts and representation in Japan.